A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031)
Public ClinicalTrials.gov record NCT05442775. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the long-term safety and tolerability of reldesemtiv in patients with ALS who have successfully completed dosing in the Phase 3 clinical trial, CY 5031 (also known as COURAGE-ALS)
Study identification
- NCT ID
- NCT05442775
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 71 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 4, 2022 (Actual)
- Primary completion
- Jun 7, 2023 (Actual)
- Completion
- Jun 7, 2023 (Actual)
- Last update posted
- Aug 13, 2024
2022 – 2023
United States locations
- U.S. sites
- 21
- U.S. states
- 16
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph's Hospital & Medical Center - Barrow Neurological Institute | Phoenix | Arizona | 85013 | — |
| University of California Irvine - ALS & Neuromuscular Center | Orange | California | 92868 | — |
| California Pacific Medical Center - Forbes Norris MDA/ALS Research Center | San Francisco | California | 94109 | — |
| University of Colorado Hospital Anschutz Outpatient Pavilion | Aurora | Colorado | 80045 | — |
| George Washington Medical Faculty Associates | Washington D.C. | District of Columbia | 20037 | — |
| University of Florida | Jacksonville | Florida | 32209 | — |
| Mayo Clinic Jacksonville | Jacksonville | Florida | 32224 | — |
| University of South Florida - Carol and Frank Morsani Center for Advanced Health Care | Tampa | Florida | 33612 | — |
| Indiana University IU Health Neuroscience Center | Indianapolis | Indiana | 43202 | — |
| The University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Johns Hopkins Outpatient Center | Baltimore | Maryland | 21287 | — |
| Michigan Medicine | Ann Arbor | Michigan | 48109 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Neurology Associates | Lincoln | Nebraska | 68506 | — |
| Hospital for Special Surgery | New York | New York | 10021 | — |
| SUNY Upstate Medical University Institute for Human Performance | Syracuse | New York | 13210 | — |
| Atrium Health Neuroscience Institute | Charlotte | North Carolina | 28207 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Texas Neurology, P.A. | Dallas | Texas | 75206 | — |
| Virginia Commonwealth University | Henrico | Virginia | 23233 | — |
| Froedtert Hospital - Department of Neurology | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05442775, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 13, 2024 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05442775 live on ClinicalTrials.gov.